Zou Ruiyang
Fondateur chez MiRXES Pte Ltd.
Profil
Zou Ruiyang is the founder of MiRXES Pte Ltd.
(founded in 2015) where he holds the title of Chief Technology Officer.
He is also the founder of Ark Bio Holding Pte Ltd.
(founded in 2018) where he holds the title of Chief Technology Officer & Director.
Additionally, Dr. Ruiyang is the founder of Mirxes Holding Co., Ltd.
(founded in 2014) where he holds the title of Deputy CEO, Executive Director & CTO.
Dr. Ruiyang's current job is at MiRXES Corp.
where he holds the titles of President, Secretary & Treasurer.
Dr. Ruiyang obtained a doctorate degree from the National University of Singapore in 2014.
He also holds undergraduate degrees from Tianjin University and Nankai University, both conferred in 2007.
Postes actifs de Zou Ruiyang
| Sociétés | Poste | Début |
|---|---|---|
MiRXES Pte Ltd.
 MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Fondateur | 01/05/2015 |
Ark Bio Holding Pte Ltd.
 Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | Fondateur | 01/01/2018 |
MiRXES Corp.
 MiRXES Corp. Medical/Nursing ServicesHealth Services MiRXES Corp. operates medical laboratories. The private company is based in Cambridge, MA. | President | - |
Mirxes Holding Co., Ltd.
 Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Fondateur | 01/05/2014 |
Formation de Zou Ruiyang
| National University of Singapore | Doctorate Degree |
| Tianjin University | Undergraduate Degree |
| Nankai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | Commercial Services |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | Finance |
MiRXES Corp.
MiRXES Corp. Medical/Nursing ServicesHealth Services MiRXES Corp. operates medical laboratories. The private company is based in Cambridge, MA. | Health Services |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Finance |
